Pharma & Healthcare

Global Gastrointestinal Market Research Report 2026

This report delivers a comprehensive overview of the global Gastrointestinal market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Gastrointestinal. The Gastrointestinal market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Gastrointestinal market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Gastrointestinal manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Gastrointestinal companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2021–2032)
2.2 Global Gastrointestinal Growth Trends by Region
2.2.1 Global Gastrointestinal Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Gastrointestinal Historic Market Size by Region (2021–2026)
2.2.3 Gastrointestinal Forecasted Market Size by Region (2027–2032)
2.3 Gastrointestinal Market Dynamics
2.3.1 Gastrointestinal Industry Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2021–2026)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2021–2026)
3.2 Global Top Gastrointestinal Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2025
3.5 Global Key Players of Gastrointestinal Head Offices and Areas Served
3.6 Global Key Players of Gastrointestinal, Products and Applications
3.7 Global Key Players of Gastrointestinal, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2021–2026)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2027–2032)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2021–2026)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Gastrointestinal Market Size (2021–2032)
6.2 North America Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Gastrointestinal Market Size by Country (2021–2026)
6.4 North America Gastrointestinal Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2021–2032)
7.2 Europe Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Gastrointestinal Market Size by Country (2021–2026)
7.4 Europe Gastrointestinal Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2021–2032)
8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Gastrointestinal Market Size by Region (2021–2026)
8.4 Asia-Pacific Gastrointestinal Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2021–2032)
9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Gastrointestinal Market Size by Country (2021–2026)
9.4 Latin America Gastrointestinal Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2021–2032)
10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Gastrointestinal Market Size by Country (2021–2026)
10.4 Middle East & Africa Gastrointestinal Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Details
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2021–2026)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2021–2026)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2021–2026)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2021–2026)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2021–2026)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2021–2026)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Details
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2021–2026)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2021–2026)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2021–2026)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2021–2026)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Details
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2021–2026)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2021–2026)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Details
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2021–2026)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Details
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2021–2026)
11.14.5 Xian-Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Prescription Gastrointestinal Drug
Table 3. Key Players of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Gastrointestinal Market Size by Region (US$ Million), 2021–2026
Table 7. Global Gastrointestinal Market Share by Region (2021–2026)
Table 8. Global Gastrointestinal Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Gastrointestinal Market Share by Region (2027–2032)
Table 10. Gastrointestinal Market Trends
Table 11. Gastrointestinal Market Drivers
Table 12. Gastrointestinal Market Challenges
Table 13. Gastrointestinal Market Restraints
Table 14. Global Gastrointestinal Revenue by Players (US$ Million), 2021–2026
Table 15. Global Gastrointestinal Market Share by Players (2021–2026)
Table 16. Global Top Gastrointestinal Players by Tier (Tier 1, Tier 2, and Tier 3), based on Gastrointestinal Revenue, 2025
Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Gastrointestinal, Headquarters and Area Served
Table 20. Global Key Players of Gastrointestinal, Products and Applications
Table 21. Global Key Players of Gastrointestinal, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Market Size by Type (US$ Million), 2021–2026
Table 24. Global Gastrointestinal Revenue Market Share by Type (2021–2026)
Table 25. Global Gastrointestinal Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Gastrointestinal Revenue Market Share by Type (2027–2032)
Table 27. Global Gastrointestinal Market Size by Application (US$ Million), 2021–2026
Table 28. Global Gastrointestinal Revenue Market Share by Application (2021–2026)
Table 29. Global Gastrointestinal Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Gastrointestinal Revenue Market Share by Application (2027–2032)
Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Gastrointestinal Market Size by Country (US$ Million), 2021–2026
Table 33. North America Gastrointestinal Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Gastrointestinal Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Gastrointestinal Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Gastrointestinal Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Gastrointestinal Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Gastrointestinal Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Gastrointestinal Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Gastrointestinal Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Gastrointestinal Market Size by Country (US$ Million), 2027–2032
Table 46. AstraZenec Company Details
Table 47. AstraZenec Business Overview
Table 48. AstraZenec Gastrointestinal Product
Table 49. AstraZenec Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 50. AstraZenec Recent Development
Table 51. Sanofi Company Details
Table 52. Sanofi Business Overview
Table 53. Sanofi Gastrointestinal Product
Table 54. Sanofi Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 55. Sanofi Recent Development
Table 56. Bayer Company Details
Table 57. Bayer Business Overview
Table 58. Bayer Gastrointestinal Product
Table 59. Bayer Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 60. Bayer Recent Development
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Gastrointestinal Product
Table 64. Pfizer Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Gastrointestinal Product
Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 70. GlaxoSmithKline Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Gastrointestinal Product
Table 74. Teva Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 75. Teva Recent Development
Table 76. Zeria（Tillotts） Company Details
Table 77. Zeria（Tillotts） Business Overview
Table 78. Zeria（Tillotts） Gastrointestinal Product
Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 80. Zeria（Tillotts） Recent Development
Table 81. Perrigo Company Details
Table 82. Perrigo Business Overview
Table 83. Perrigo Gastrointestinal Product
Table 84. Perrigo Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 85. Perrigo Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Gastrointestinal Product
Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 90. Boehringer Ingelheim Recent Development
Table 91. Purdue Pharma Company Details
Table 92. Purdue Pharma Business Overview
Table 93. Purdue Pharma Gastrointestinal Product
Table 94. Purdue Pharma Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 95. Purdue Pharma Recent Development
Table 96. C.B. Fleet Company Details
Table 97. C.B. Fleet Business Overview
Table 98. C.B. Fleet Gastrointestinal Product
Table 99. C.B. Fleet Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 100. C.B. Fleet Recent Development
Table 101. Abbott Company Details
Table 102. Abbott Business Overview
Table 103. Abbott Gastrointestinal Product
Table 104. Abbott Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 105. Abbott Recent Development
Table 106. Jiangzhong Company Details
Table 107. Jiangzhong Business Overview
Table 108. Jiangzhong Gastrointestinal Product
Table 109. Jiangzhong Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 110. Jiangzhong Recent Development
Table 111. Xian-Janssen Company Details
Table 112. Xian-Janssen Business Overview
Table 113. Xian-Janssen Gastrointestinal Product
Table 114. Xian-Janssen Revenue in Gastrointestinal Business (US$ Million), 2021–2026
Table 115. Xian-Janssen Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report


List of Figures
Figure 1. Gastrointestinal Picture
Figure 2. Global Gastrointestinal Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Gastrointestinal Market Share by Type: 2025 vs 2032
Figure 4. Prescription Gastrointestinal Drug Features
Figure 5. OTC Gastrointestinal Drug Features
Figure 6. Global Gastrointestinal Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Gastrointestinal Market Share by Application: 2025 vs 2032
Figure 8. Chronic Gastritis Case Studies
Figure 9. Functional Dyspepsia Case Studies
Figure 10. Peptic Ulcer Case Studies
Figure 11. Acute Gastroenteritis Case Studies
Figure 12. Others Case Studies
Figure 13. Gastrointestinal Report Years Considered
Figure 14. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Gastrointestinal Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Gastrointestinal Market Share by Region: 2025 vs 2032
Figure 17. Global Gastrointestinal Market Share by Players in 2025
Figure 18. Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2025
Figure 20. North America Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Gastrointestinal Market Share by Country (2021–2032)
Figure 22. United States Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Gastrointestinal Market Share by Country (2021–2032)
Figure 26. Germany Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Gastrointestinal Market Share by Region (2021–2032)
Figure 34. China Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Gastrointestinal Market Share by Country (2021–2032)
Figure 42. Mexico Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Gastrointestinal Market Share by Country (2021–2032)
Figure 46. Israel Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Gastrointestinal Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 50. Sanofi Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 51. Bayer Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 52. Pfizer Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 53. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 54. Teva Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 55. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 56. Perrigo Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 58. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 59. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 60. Abbott Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 61. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 62. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2021–2026)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies